Our study preliminarily explored the relationship between GOT2 and the prognosis of patients with hepatocellular carcinoma and preliminarily explored its effect on the migration ability of hepatocellular carcinoma. This evidence concerns the gene GOT2 and hepatocellular carcinoma.